This study is looking for young people aged 10 to 24 who have Major Depressive Disorder (MDD) or suicidal thoughts. The goal is to find biological markers (biomarkers) in your blood, specifically neural-derived plasma exosomal microRNAs (tiny genetic material), that might help identify the risk for suicidal thoughts and actions. Researchers will use genetic testing to look for these biomarkers. They also want to see how standard depression treatment affects these biomarkers and your depressive and suicidal behaviors. The study aims to improve future medical and psychiatric care. Success will be measured by analyzing your clinical symptoms after 6 weeks. The current recruitment status is unclear.

Study design

This interventional study plans to enroll 240 participants aged 10 to 24. It involves genetic testing to identify biomarkers.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your clinical symptoms will be analyzed at 6 weeks after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.